drugset / Trial / NCT05551624
Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the ability of Atorvastatin and N-acetyl cysteine to elevate the blood (serum) platelet count in patients with Immune Thrombocytopenia as a mean of a new treatment.
Timeline
- Start
- 2018-07-04
- Primary completion
- 2019-12-11
- Completion
- 2020-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | Oral |
| Subject | N-acetylcysteine | Small molecule | 400 mg | Oral |